products

Filter by Research Categories:

ALL COGNITIVE & NEURO DERMAL, HAIR & TISSUE APPEARANCE GLP-1 GLP-2 GLP-3 GROWTH & REPAIR IMMUNE & INFLAMMATORY METABOLIC MITOCHONDRIAL & CELLULAR ENERGY ONCOLOGY & CELL FATE REGENERATION & LONGEVITY REPRODUCTIVE & NEUROENDOCRINE SUPPLIES & ACCESSORIES Uncategorized
  • Adipotide
    • Adipotide

    • Adipotide

    • Price range: $ 90 through $ 170
    • A proapoptotic peptide that selectively targets and destroys blood vessels supplying white adipose tissue. By cutting off blood supply to fat cells, it causes rapid adipose reduction. Studied for obesity treatment in primates with impressive results
    • Select options This product has multiple variants. The options may be chosen on the product page
  • Cagrilintide
    • Cagrilintide

    • Cagrilintide

    • Price range: $ 44 through $ 88
    • A long-acting amylin analogue. Amylin is co-secreted with insulin and regulates satiety signals in the brain. Cagrilintide slows gastric emptying, reduces food intake, and when combined with semaglutide (CagriSema), produces synergistic weight loss.
    • Select options This product has multiple variants. The options may be chosen on the product page
  • Cagrilintide 5mg + Sema 5mg
    • Cagrilintide 5mg + Sema 5mg

    • Cagrilintide 5mg + Sema 5mg

    • $ 170
    • Combines semaglutide, a GLP-1 receptor agonist approved (as Ozempic/Wegovy) for type 2 diabetes and chronic weight management, with cagrilintide, a long-acting amylin receptor agonist studied in clinical trials for additive weight loss when co-administered with GLP-1 therapy.
    • Select options This product has multiple variants. The options may be chosen on the product page
  • GLP-3 (R)
    • GLP-3 (R)
    • ,

    • GLP-3 (R)

    • Price range: $ 53 through $ 257
    • A triple agonist targeting GLP-1, GIP, and glucagon receptors simultaneously. Considered a next-generation obesity drug. The glucagon component boosts energy expenditure and liver fat metabolism, while GLP-1 and GIP reduce appetite and improve insulin action.
    • Select options This product has multiple variants. The options may be chosen on the product page
  • L-Carnitine
    • L-Carnitine

    • L-Carnitine

    • $ 49
    • An amino acid derivative (from lysine and methionine) that transports long-chain fatty acids into mitochondria for beta-oxidation (fat burning). Essential for energy metabolism. Used for weight loss, athletic performance, heart health, and male fertility.
    • Select options This product has multiple variants. The options may be chosen on the product page
  • LC120
    • LC120

    • LC120

    • $ 49
    • A lipotropic injection blend containing Methionine, Choline Chloride, L-Carnitine, and Dexpanthenol (Vitamin B5). These four compounds collectively support fat transport from the liver, fat cell metabolism, and energy production. A foundational Lipo-C formula without B12 or inositol.
    • Select options This product has multiple variants. The options may be chosen on the product page
  • LC216
    • LC216

    • LC216

    • $ 49
    • An enhanced lipotropic injection formula building on LC120, typically adding Inositol and/or Pyridoxine (B6) to the base of Methionine, Choline, L-Carnitine, and B5. Inositol improves insulin sensitivity and fat emulsification. The combined '216mg' formula provides broader metabolic support than the 120 formula.
    • Select options This product has multiple variants. The options may be chosen on the product page
  • LC526 (FatBlaster)
    • LC526 (FatBlaster)

    • LC526 (FatBlaster)

    • $ 85
    • The most comprehensive Lipo-C formula. Contains L-Carnitine 300mg, Methionine 25mg, Inositol 50mg, Choline 50mg, Vitamin B12 1mg, Vitamin B6 50mg, and NADH 50mg per ml. NADH is a coenzyme form of B3 that directly fuels cellular energy (ATP) production and supports mitochondrial fat oxidation — making this the most metabolically active of the LC serie
    • Select options This product has multiple variants. The options may be chosen on the product page
  • Retatrutide + Cagrilintide
    • Retatrutide + Cagrilintide

    • Retatrutide + Cagrilintide

    • $ 118
    • Retatrutide is an investigational triple agonist acting on GLP-1, GIP, and glucagon receptors, studied in Phase 2/3 obesity and MASLD trials with weight-loss results exceeding single/dual agonists. Paired here with cagrilintide (long-acting amylin receptor agonist) for combined appetite/metabolic research.
    • Select options This product has multiple variants. The options may be chosen on the product page
  • Survodutide
    • Survodutide

    • Survodutide

    • $ 250
    • A dual glucagon/GLP-1 receptor agonist currently in Phase 3 trials. The glucagon component amplifies energy expenditure and liver fat reduction, while GLP-1 handles appetite and insulin effects. Positioned for both obesity and MASH (metabolic fatty liver disease).
    • Select options This product has multiple variants. The options may be chosen on the product page